Bevacizumab Slows Ovarian Cancer Progression

posted on Feb 25 by MedPage Today OB/Gyn in the Uncategorized category Maintenance therapy with bevacizumab (Avastin) following combination therapy with the drug and chemotherapy improved progression-free survival in women with previously untreated advanced ovarian cancer, drugmaker Genentech announced.